Posaconazole achieves prompt recovery of voriconazole-induced liver injury in a case of invasive aspergillosis
Open Access
- 1 March 2018
- journal article
- case report
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 11, 317-321
Abstract
Azole antifungals have frequently been linked to the presence of hepatotoxicity, but there is scarce information on cross-toxicity between these drugs or on the possibility of using some of them when this type of toxicity occurs. We report the case of a 64-year-old man with invasive aspergillosis (IA) leading to spondylodiscitis with neurological involvement. Early management included intravenous (iv) voriconazole, which had to be interrupted after 1 week due to liver damage. Therapeutic drug monitoring (TDM) of voriconazole showed that the plasma concentration was within the therapeutic range. However, it was replaced by a combination therapy of oral posaconazole plus iv caspofungin. Posaconazole allowed normalization of liver enzymes. After finishing posaconazole monotherapy on an outpatient basis, the patient made a full recovery. This case report provides further evidence that oral posaconazole is safe and effective as rescue therapy after the appearance of voriconazole-induced liver toxicity.Keywords
This publication has 18 references indexed in Scilit:
- Impact of special patient populations on the pharmacokinetics of echinocandinsExpert Review of Anti-infective Therapy, 2015
- Voriconazole Metabolism, Toxicity, and the Effect of Cytochrome P450 2C19 GenotypeThe Journal of Infectious Diseases, 2014
- Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical MycologyJournal of Antimicrobial Chemotherapy, 2013
- Combination antifungal therapy for invasive fungal infections in children and adultsExpert Review of Anti-infective Therapy, 2013
- Posaconazole after previous antifungal therapy with voriconazole for therapy of invasive aspergillus disease, a retrospective analysisMycoses, 2012
- Systematic Review and Meta-Analysis of the Tolerability and Hepatotoxicity of Antifungals in Empirical and Definitive Therapy for Invasive Fungal InfectionAntimicrobial Agents and Chemotherapy, 2010
- Tolerability and safety profile of posaconazole: evaluation of 18 controlled studies in healthy volunteersJournal of Clinical Pharmacy and Therapeutics, 2009
- Lack of Cross-Hepatotoxicity between Voriconazole and PosaconazoleClinical Infectious Diseases, 2007
- Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive AspergillosisClinical Infectious Diseases, 2002
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981